Correlation Between Enliven Therapeutics and Amgen

Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enliven Therapeutics and Amgen Inc, you can compare the effects of market volatilities on Enliven Therapeutics and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Amgen.

Diversification Opportunities for Enliven Therapeutics and Amgen

-0.18

Correlation Coefficient

Enliven Therapeutics  Amgen

Good diversification

The 3 months correlation between Enliven and Amgen is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Amgen go up and down completely randomly.

Pair Corralation between Enliven Therapeutics and Amgen

Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Amgen. In addition to that, Enliven Therapeutics is 1.32 times more volatile than Amgen Inc. It trades about -0.19 of its total potential returns per unit of risk. Amgen Inc is currently generating about -0.21 per unit of volatility. If you would invest  31,440  in Amgen Inc on September 3, 2024 and sell it today you would lose (3,153) from holding Amgen Inc or give up 10.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Enliven Therapeutics  vs.  Amgen Inc

Enliven Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Amgen Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Enliven Therapeutics and Amgen

The main advantage of trading using opposite Enliven Therapeutics and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.

The idea behind Enliven Therapeutics and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.